MAIA Biotechnology Statistics
NYSE: MAIAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.14-0.045 (-3.81%)
Market open · Delayed 15 min · as of Oct 8, 11:13 AM ET
MAIA Biotechnology by the numbers
MAIA Biotechnology has a market capitalization of $70.1 million based on 61.74M shares outstanding. With trailing EPS of $-0.62, MAIA Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.9% below its 50-day average and 23.9% below its 200-day average.
Average daily trading volume is 525.87K shares, or about $596,864 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MAIA valuation vs. peer median
| Metric | MAIA | Peer median | Difference |
|---|---|---|---|
| Market cap | $70.08M | $72.99M | -4% |
| Avg. volume | 525.87K | 344.68K | +53% |
Peer median across 8 companies: ONCY, OSTX, NTHI, PDSB, GANX, VRCA, LFVN, CING.
Valuation
- Market cap
- $70.08M
- Forward P/E
- 1.02
- EPS (TTM)
- $-0.62
- Shares outstanding
- 61.74M
Price and trading
- Previous close
- 1.18
- Open
- 1.15
- Day range
- 1.13 – 1.16
- 52-week range
- 0.87 – 3.19
- 52-week change
- -34.08%
- Beta
- —
- Volume
- 290.87K
- Average volume
- 525.87K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 70.08M
- Forward Pe
- 1.02
- Eps
- -0.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.19
- Week52 Low
- 0.87
- Avg Volume
- 525.87K
- Shares Outstanding
- 61.74M
- Ma50
- 1.32
- Ma200
- 1.49
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -64.42%
- Pct From52w Low
- 30.46%